Jindal, Rahul M <br/><br/>
Outcomes in African-Americans vs. Caucasians using thymoglobulin or interleukin-2 receptor inhibitor induction: analysis of USRDS database.  [electronic resource] 

 -  American journal of nephrology  2009 
 - 501-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1421-9670 
<br/><br/><label>Standard No.: </label>10.1159/000182816  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American<br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antilymphocyte Serum<br/>Basiliximab<br/>Cohort Studies<br/>Daclizumab<br/>Databases, Factual<br/>Female<br/>Graft Rejection--ethnology<br/>Graft Survival<br/>Humans<br/>Immunoglobulin G--pharmacology<br/>Immunosuppressive Agents--pharmacology<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Rabbits<br/>Receptors, Interleukin-2--antagonists & inhibitors<br/>Recombinant Fusion Proteins--pharmacology<br/>Retrospective Studies<br/>United States--epidemiology<br/>White People<br/>Young Adult